Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review

Hana A Mansour, Chiara M Eandi, Francesco Pichi, Robert E Foster, Suzanne A Charbaji, Debdulal Chakraborty, Abdallah A Ellabban, Silvana Belotto, Hashem Abu Serhan, Simon Magnin, Lorenzo Lopez-Guajardo, Eduardo Pérez-Salvador García, Stephen G Schwartz, Michael W Stewart, Amanda Rey, Ignasi Jürgens, Antonio MB Casella, Anubhav Upadhyay, Jay U Sheth, Luiz H Lima, Suthasinee Sinawat, Santiago Abengoechea, Maria Jose Capella, Sonia Viver Oller, Javier Elizalde, Wajiha J Kheir, Danny Mammo, Gabriel Castilho Sandoval Barbosa, Victor M Villegas, Arjun Desai, Koushik Tripathy, Suraj Bala, Nitesh Mohan, Ayman G Elnahry, Sami H Uwaydat, Daniel G Cherfan, Maurizio Battaglia Parodi, Ahmad M Mansour

Open source

DOI: 10.2147/opth.s622037
Published: 2026-07
Container: Clinical Ophthalmology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/opth.s622037,
  title = {Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review},
  author = {Hana A Mansour and Chiara M Eandi and Francesco Pichi and Robert E Foster and Suzanne A Charbaji and Debdulal Chakraborty and Abdallah A Ellabban and Silvana Belotto and Hashem Abu Serhan and Simon Magnin and Lorenzo Lopez-Guajardo and Eduardo Pérez-Salvador García and Stephen G Schwartz and Michael W Stewart and Amanda Rey and Ignasi Jürgens and Antonio MB Casella and Anubhav Upadhyay and Jay U Sheth and Luiz H Lima and Suthasinee Sinawat and Santiago Abengoechea and Maria Jose Capella and Sonia Viver Oller and Javier Elizalde and Wajiha J Kheir and Danny Mammo and Gabriel Castilho Sandoval Barbosa and Victor M Villegas and Arjun Desai and Koushik Tripathy and Suraj Bala and Nitesh Mohan and Ayman G Elnahry and Sami H Uwaydat and Daniel G Cherfan and Maurizio Battaglia Parodi and Ahmad M Mansour},
  year = {2026},
  journal = {Clinical Ophthalmology},
  doi = {10.2147/opth.s622037},
  url = {https://doi.org/10.2147/opth.s622037}
}

RIS

TY  - JOUR
TI  - Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
AU  - Hana A Mansour
AU  - Chiara M Eandi
AU  - Francesco Pichi
AU  - Robert E Foster
AU  - Suzanne A Charbaji
AU  - Debdulal Chakraborty
AU  - Abdallah A Ellabban
AU  - Silvana Belotto
AU  - Hashem Abu Serhan
AU  - Simon Magnin
AU  - Lorenzo Lopez-Guajardo
AU  - Eduardo Pérez-Salvador García
AU  - Stephen G Schwartz
AU  - Michael W Stewart
AU  - Amanda Rey
AU  - Ignasi Jürgens
AU  - Antonio MB Casella
AU  - Anubhav Upadhyay
AU  - Jay U Sheth
AU  - Luiz H Lima
AU  - Suthasinee Sinawat
AU  - Santiago Abengoechea
AU  - Maria Jose Capella
AU  - Sonia Viver Oller
AU  - Javier Elizalde
AU  - Wajiha J Kheir
AU  - Danny Mammo
AU  - Gabriel Castilho Sandoval Barbosa
AU  - Victor M Villegas
AU  - Arjun Desai
AU  - Koushik Tripathy
AU  - Suraj Bala
AU  - Nitesh Mohan
AU  - Ayman G Elnahry
AU  - Sami H Uwaydat
AU  - Daniel G Cherfan
AU  - Maurizio Battaglia Parodi
AU  - Ahmad M Mansour
PY  - 2026
JO  - Clinical Ophthalmology
DO  - 10.2147/opth.s622037
UR  - https://doi.org/10.2147/opth.s622037
ER  -

APA

Mansour, H. A., Eandi, C. M., Pichi, F., Foster, R. E., Charbaji, S. A., Chakraborty, D., Ellabban, A. A., Belotto, S., Serhan, H. A., Magnin, S., Lopez-Guajardo, L., García, E. P., Schwartz, S. G., Stewart, M. W., Rey, A., Jürgens, I., Casella, A. M., Upadhyay, A., Sheth, J. U., Lima, L. H., Sinawat, S., Abengoechea, S., Capella, M. J., Oller, S. V., Elizalde, J., Kheir, W. J., Mammo, D., Barbosa, G. C. S., Villegas, V. M., Desai, A., Tripathy, K., Bala, S., Mohan, N., Elnahry, A. G., Uwaydat, S. H., Cherfan, D. G., Parodi, M. B., & Mansour, A. M. (2026). Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. Clinical Ophthalmology. https://doi.org/10.2147/opth.s622037

Source records

crossref · retrieved 2026-09-25T20:35:57.605Z